However, the effect of in vivo P2Et treatment was partially lost when simultaneous depletion of CD4 and CD8 T cells was done, suggesting that both CD4 and CD8 T cells were important for P2Et anti-tumor activity (Figure 6d). This evidence concerns the gene CD4 and neoplasm.